Daily cannabis news
The cannabis news that matters, every day.
Laws, markets and industry trends from across North America and beyond, explained clearly and without the hype.
Latest headlines
-
Buying Tesamorelin in the UK: Research Sourcing and Quality Checks
The short version: Tesamorelin is a synthetic GHRH analog that is FDA-approved under the brand name Egrifta for HIV-associated lipodystrophy, but it is not licensed in the UK. Research-grade tesamorelin…
What we cover
Three beats we follow closely.
01
Laws & regulation
Legalization updates, licensing changes and the rules that shape how cannabis is sold.
02
Markets & business
Sales data, mergers, store openings and the trends driving the industry.
03
Products & culture
New formats, consumer habits and the stories behind the brands.
How we report
Every story follows the same simple standards.
- Primary sources first: laws, filings and official data
- Clear separation of news and opinion
- Corrections published promptly
- Plain language, with jargon explained
Frequently asked questions
How often is Get Cannabis Daily updated?
We publish new stories and roundups throughout the week, with the latest always at the top of our news page.
Do you cover medical cannabis?
We cover medical cannabis news and policy, but we do not give medical advice. Speak with a healthcare professional about your own situation.
Can I suggest a story?
Yes. Send tips and story ideas through our contact page and our editors will take a look.
Never miss a headline
Catch up on the latest cannabis news and industry analysis.